Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biodistribution of AlbudAb GSK3128349 in Healthy Males
NCT02829307Phase 1Completed
- Sponsor
- GSK
- Start
- Aug 2016
- Primary completion
- Jan 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of GSK3128349, sponsored by GSK. Primary endpoints: Mean Standardized Uptake Values Derived From PET-CT Data and Mean Volume of Region of Interest for Each Organ. Started Aug 2016; status: completed.
02
Drugs
GSK3128349
Beyond the preview
Go deeper on NCT02829307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829307.